Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part of Johnson ...

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut ...

Kenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry succeeding him as the interim chief executive officer, effective immediately.

Kenvue shares were up by more than 6% during pre-market on the back of the announcement. Board director Kirk Perry has been named interim CEO while the company undergoes a strategic review aimed at ...

Kenvue Inc. (NYSE:KVUE) is one of the 10 Stocks with Huge Catalysts on the Horizon. The company names an interim CEO and ...

Kenvue announced Chief Executive Thibaut Mongon has departed the firm, and Kirk Perry, one of its directors, will serve as the interim CEO while the firm finds a permanent successor.

(RTTNews) - Consumer health company Kenvue, Inc. (KVUE) announced Monday that its Board of Directors has appointed Kirk Perry as Interim Chief Executive Officer, effective immediately.

Kenvue said Monday that board member Kirk Perry will serve as interim CEO, effective immediately. Perry has served as a director since December and most recently served as CEO of Circana, a ...

The basics: CEO Thibaut Mongon departs; Kirk Perry named interim leader Board launches strategic review to explore business options Perry brings 30+ years of global CPG, tech experience ...

Kenvue named director Kirk Perry as interim CEO, while Mongon also stepped down from the board. Perry, who worked at Procter & Gamble (PG.N) for 23 years, most recently served as CEO of technology ...

Kenvue said Monday that board member Kirk Perry will serve as interim CEO, effective immediately. Perry has served as a director since December and most recently served as CEO of Circana, a ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, named director Kirk Perry as interim chief executive officer as Thibaut Mongon departs the company.